NZ530743A - Solid composition containing bacillus-type non-pathogenic bacterial spores - Google Patents

Solid composition containing bacillus-type non-pathogenic bacterial spores

Info

Publication number
NZ530743A
NZ530743A NZ530743A NZ53074302A NZ530743A NZ 530743 A NZ530743 A NZ 530743A NZ 530743 A NZ530743 A NZ 530743A NZ 53074302 A NZ53074302 A NZ 53074302A NZ 530743 A NZ530743 A NZ 530743A
Authority
NZ
New Zealand
Prior art keywords
composition
spores
billion
approximately
microcrystalline cellulose
Prior art date
Application number
NZ530743A
Other languages
English (en)
Inventor
Tiziano Prato
Original Assignee
Sanofi Synthelabo Otc S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo Otc S filed Critical Sanofi Synthelabo Otc S
Publication of NZ530743A publication Critical patent/NZ530743A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pretreatment Of Seeds And Plants (AREA)
NZ530743A 2001-07-27 2002-07-26 Solid composition containing bacillus-type non-pathogenic bacterial spores NZ530743A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2001MI001632A ITMI20011632A1 (it) 2001-07-27 2001-07-27 Composizione solida contenente spore di batteri non patogeni del genere bacillus
PCT/EP2002/008384 WO2003011341A1 (fr) 2001-07-27 2002-07-26 Composition solide contenant des spores de bacteries non pathogenes du genre bacillus

Publications (1)

Publication Number Publication Date
NZ530743A true NZ530743A (en) 2005-08-26

Family

ID=11448170

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ530743A NZ530743A (en) 2001-07-27 2002-07-26 Solid composition containing bacillus-type non-pathogenic bacterial spores

Country Status (32)

Country Link
US (2) US8039006B2 (no)
EP (1) EP1429808B1 (no)
JP (1) JP4913986B2 (no)
KR (2) KR20090099022A (no)
CN (1) CN1323720C (no)
AT (1) ATE462448T1 (no)
AU (1) AU2002333278B2 (no)
BR (1) BRPI0211453B1 (no)
CA (1) CA2454389C (no)
CO (1) CO5560587A2 (no)
CY (1) CY1112608T1 (no)
DE (1) DE60235819D1 (no)
DK (1) DK1429808T3 (no)
EA (1) EA006847B1 (no)
ES (1) ES2356325T3 (no)
GE (2) GEP20063721B (no)
HK (1) HK1061644A1 (no)
HR (1) HRP20040066B1 (no)
HU (1) HU229652B1 (no)
IL (2) IL159807A0 (no)
IT (1) ITMI20011632A1 (no)
MA (1) MA27051A1 (no)
MX (1) MXPA04000835A (no)
NO (1) NO332656B1 (no)
NZ (1) NZ530743A (no)
PL (1) PL209647B1 (no)
PT (1) PT1429808E (no)
SI (1) SI1429808T1 (no)
TN (1) TNSN04018A1 (no)
UA (1) UA81225C2 (no)
WO (1) WO2003011341A1 (no)
ZA (1) ZA200400440B (no)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6599631B2 (en) 2001-01-26 2003-07-29 Nanogram Corporation Polymer-inorganic particle composites
KR100931948B1 (ko) * 2007-06-26 2009-12-15 영남대학교 산학협력단 제올라이트를 이용한 바실러스 포자의 열 안정성 향상 방법
BE1018018A6 (nl) 2008-02-28 2010-04-06 Gielen Cornelis Oplossing voor het biologisch reinigen van tandenborstels en bijhorende inrichting.
BR122016030511B1 (pt) 2008-04-07 2017-07-04 Bayer Intellectual Property Gmbh Composition understanding biological control and fungicid agents, method for treating a plant, and spray formulation for treatment or application in sulco
KR20110007168A (ko) * 2008-04-07 2011-01-21 바이엘 크롭사이언스 엘피 안정한 포자-함유 수성 제제
IT1393931B1 (it) * 2009-02-25 2012-05-17 Neuroscienze Pharmaness S C A R L Composizione di spore di batteri non patogeni
WO2011120530A1 (en) * 2010-03-31 2011-10-06 Lifecycle Phama A/S Porous tablets as carriers for liquid formulations
US8906668B2 (en) 2012-11-23 2014-12-09 Seres Health, Inc. Synergistic bacterial compositions and methods of production and use thereof
SG10201704035TA (en) * 2012-11-23 2017-06-29 Seres Therapeutics Inc Synergistic bacterial compositions and methods of production and use thereof
KR102222273B1 (ko) 2013-02-04 2021-03-08 세레스 테라퓨틱스, 인코포레이티드 조성물 및 방법
EP2951283A4 (en) 2013-02-04 2017-01-25 Seres Therapeutics, Inc. Compositions and methods
AU2014232370B2 (en) 2013-03-15 2018-11-01 Seres Therapeutics, Inc. Network-based microbial compositions and methods
KR102379658B1 (ko) 2013-11-25 2022-03-28 세레스 테라퓨틱스, 인코포레이티드 상승적 박테리아 조성물 및 그것의 생산 방법 및 용도
US9956282B2 (en) 2013-12-16 2018-05-01 Seres Therapeutics, Inc. Bacterial compositions and methods of use thereof for treatment of immune system disorders
EP3668527A1 (en) 2017-08-14 2020-06-24 Seres Therapeutics, Inc. Compositions and methods for treating cholestatic disease
US11278578B2 (en) * 2018-09-02 2022-03-22 Sanzyme Biologics Private Limited Combination probiotic compositions and uses thereof
FR3125945A1 (fr) * 2021-08-03 2023-02-10 Setalg Composition pour protéger un microorganisme dans un environnement acide.

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1061894A (en) 1963-03-01 1967-03-15 Lucien Nouvel Therapeutically active bacterial preparations
GB8425487D0 (en) * 1984-10-09 1984-11-14 Agricultural Genetics Co Strain of bacillus thuringiensis
DE3707160A1 (de) * 1987-03-06 1988-09-15 Hoechst Ag Bacillus polymyxa enthaltende mittel zur verabreichung an tiere
JPH0761255B2 (ja) 1990-10-31 1995-07-05 旭化成工業株式会社 安定化芽胞形成生菌製剤の製造法
DE4404702A1 (de) * 1994-02-15 1995-08-31 Hoechst Schering Agrevo Gmbh Wasserdispergierbare Granulate auf der Basis lebender Organismen
JP4194114B2 (ja) * 1994-02-23 2008-12-10 ビーエム リサーチ エイ／エス 制御放出組成物
CA2192086C (en) * 1994-06-15 2000-01-25 Tomas Norling Pellets
DE4442255A1 (de) * 1994-11-28 1996-05-30 Bayer Ag Schädlingsbekämpfungsmittel
JP3180886B2 (ja) 1995-06-07 2001-06-25 旭化成株式会社 動物成長促進剤
EP1067945B1 (en) * 1998-04-01 2006-01-04 Ganeden Biotech, Inc. Methods for reducing cholesterol using bacillus coagulans spores, systems and compositions
US6924133B1 (en) * 1999-10-01 2005-08-02 Novozymes A/S Spray dried enzyme product
US6387874B1 (en) * 2001-06-27 2002-05-14 Spartan Chemical Company, Inc. Cleaning composition containing an organic acid and a spore forming microbial composition

Also Published As

Publication number Publication date
DE60235819D1 (de) 2010-05-12
PT1429808E (pt) 2010-06-23
WO2003011341A1 (fr) 2003-02-13
HK1061644A1 (en) 2004-09-30
EA006847B1 (ru) 2006-04-28
HUP0402024A2 (hu) 2005-01-28
HUP0402024A3 (en) 2005-06-28
EP1429808A1 (fr) 2004-06-23
DK1429808T3 (da) 2010-07-19
CA2454389C (fr) 2011-07-12
CN1323720C (zh) 2007-07-04
KR20040032868A (ko) 2004-04-17
CY1112608T1 (el) 2016-02-10
MA27051A1 (fr) 2004-12-20
US8039006B2 (en) 2011-10-18
HRP20040066A2 (en) 2004-06-30
AU2002333278B2 (en) 2007-05-31
NO332656B1 (no) 2012-11-26
US8551498B2 (en) 2013-10-08
ZA200400440B (en) 2005-03-30
KR100970787B1 (ko) 2010-07-16
BRPI0211453B1 (pt) 2018-04-03
BR0211453A (pt) 2004-08-17
ITMI20011632A1 (it) 2003-01-27
IL159807A0 (en) 2004-06-20
ATE462448T1 (de) 2010-04-15
GEP20053721B (en) 2006-01-10
PL209647B1 (pl) 2011-09-30
EP1429808B1 (fr) 2010-03-31
NO20040347L (no) 2004-03-26
MXPA04000835A (es) 2004-05-14
CN1558776A (zh) 2004-12-29
SI1429808T1 (sl) 2010-11-30
EA200400072A1 (ru) 2004-08-26
UA81225C2 (en) 2007-12-25
US20120009167A1 (en) 2012-01-12
TNSN04018A1 (fr) 2006-06-01
ITMI20011632A0 (it) 2001-07-27
KR20090099022A (ko) 2009-09-18
CA2454389A1 (fr) 2003-02-13
HU229652B1 (en) 2014-03-28
US20040241772A1 (en) 2004-12-02
HRP20040066B1 (en) 2012-02-29
CO5560587A2 (es) 2005-09-30
IL159807A (en) 2010-05-31
GEP20063721B (en) 2006-01-10
JP2004538311A (ja) 2004-12-24
PL366984A1 (en) 2005-02-07
JP4913986B2 (ja) 2012-04-11
ES2356325T3 (es) 2011-04-07

Similar Documents

Publication Publication Date Title
US8551498B2 (en) Solid composition containing Bacillus-type non-pathogenic bacterial spores
Lidbeck et al. Lactobacilli and the normal human anaerobic microflora
AU2016365214B2 (en) Stable dry compositions having no or little sugars
KR101700967B1 (ko) 락토바실루스 루테리 (Ｌａｃｔｏｂａｃｉｌｌｕｓ ｒｅｕｔｅｒｉ)의 루테린-생산 복합 절차의 제어된 활성화
JP5409623B2 (ja) 亜鉛強化バイオマス、その調製方法、および、それを含むプロバイオティック品、化粧品、ダイエタリー品および栄養補給品
JPH06166626A (ja) 生菌粉末
US20240074984A1 (en) Encapsulation of live microorganisms for gastrointestinaltargeted delivery
WO2020189228A1 (ja) 腸内有用菌の増殖及び有機酸産生増強剤
RU2371479C1 (ru) Комплексный препарат-пробиотик в иммобилизованной и лиофилизированной форме
RU2159624C1 (ru) Средство для коррекции микробиоценоза
JPH03244367A (ja) 免疫増強用食品添加剤
NZ742496B2 (en) Stable dry compositions having no or little sugars
JP2001302524A (ja) 強肝剤
KR20040096284A (ko) 장내균총의 불균형 개선 및 정장효과를 지닌 장내세균제제

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 26 JUL 2016 BY CPA GLOBAL

Effective date: 20150612

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 26 JUL 2017 BY CPA GLOBAL

Effective date: 20160610

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 26 JUL 2018 BY CPA GLOBAL

Effective date: 20170608

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 26 JUL 2019 BY CPA GLOBAL

Effective date: 20180614

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 26 JUL 2020 BY CPA GLOBAL

Effective date: 20190613

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 26 JUL 2021 BY CPA GLOBAL

Effective date: 20200611

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 26 JUL 2022 BY CPA GLOBAL

Effective date: 20210610

EXPY Patent expired